Results
22
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
22 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €5.82 | 0.7% | -48.2% | €87.5m | €6.30 | PS14.5x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €12.24 | -3.8% | -42.8% | €101.1m | €20.75 | PE13.4x | E36.0% | n/a | Capital Goods | ||
VU | €137.10 | 1.2% | 27.7% | €2.2b | €193.33 | PE27.5x | E25.7% | 0.2% | Tech | ||
ALMUN | €0.45 | 0.4% | -79.6% | €4.0m | €1.30 | PB0.3x | E149.2% | n/a | Tech | ||
OSE | €7.93 | 7.3% | 133.2% | €172.5m | €11.43 | PS77.5x | E5.9% | n/a | Pharmaceuticals & Biotech | ||
FDE | €26.95 | -4.9% | -35.0% | €142.3m | €60.33 | PE18.1x | E31.9% | n/a | Energy | ||
ALICA | €9.90 | -0.8% | -28.3% | €80.1m | €16.00 | PE14.6x | E35.1% | 2.0% | Tech | ||
ALCUR | €6.18 | -1.0% | 164.1% | €35.6m | €8.48 | PE19.8x | E27.5% | n/a | Capital Goods | ||
MEDCL | €18.06 | 1.3% | 166.4% | €525.3m | €22.03 | PS44x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
ALSTI | €18.65 | 4.2% | n/a | €94.8m | €16.50 | PE47.4x | E28.5% | 1.0% | Capital Goods | ||
ALSMA | €4.18 | 2.7% | 64.6% | €21.8m | €5.80 | PE20.6x | E35.2% | n/a | Healthcare | ||
ALLIX | €8.18 | 9.2% | -21.3% | €53.7m | €13.50 | PS1.6x | E102.1% | n/a | Software | ||
ALECP | €0.66 | 65.0% | -7.6% | €81.2m | n/a | PE90.2x | E86.8% | 0% | Media | ||
ALVGO | €3.08 | -3.1% | -13.2% | €18.8m | €4.40 | PS1.5x | E77.2% | n/a | Software | ||
ALHOP | €22.90 | -2.1% | 34.7% | €65.8m | €30.40 | PE14.4x | E22.3% | 2.8% | Media | ||
ALCIS | €8.76 | 1.4% | -2.2% | €68.2m | €12.10 | PE21.4x | E56.8% | 1.8% | Commercial Services | ||
LSS | €28.00 | 1.1% | -5.1% | €1.1b | €34.58 | PE33.2x | E29.3% | 1.3% | Software | ||
OVH | €5.52 | -9.1% | -39.8% | €1.0b | €9.35 | PS1.1x | E101.1% | n/a | Software | ||
GUI | €5.30 | -7.0% | -22.1% | €79.7m | €7.85 | PE82.6x | E55.2% | 0% | Tech | ||
ALPAT | €15.90 | -2.5% | 24.2% | €17.6m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
CLA | €1.49 | 1.9% | -10.0% | €84.5m | €4.65 | PE-16.9x | E88.7% | n/a | Software | ||
EXN | €23.40 | 0.9% | 24.7% | €2.1b | €25.33 | PE51.6x | E33.7% | 0% | Software |